Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent Pain
Marco Sisignano, Philip Gribbon, Gerd Geißlinger
Drugs (2022) Vol. 82, Iss. 4, pp. 357-373
Open Access | Times Cited: 18

Showing 18 citing articles:

Neuropathic pain: Mechanisms and therapeutic strategies
Georg Petroianu, Lujain Aloum, Abdu Adem
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 33
Digital Therapeutics for Improving Effectiveness of Pharmaceutical Drugs and Biological Products: Preclinical and Clinical Studies Supporting Development of Drug + Digital Combination Therapies for Chronic Diseases
Zack Biskupiak, Victor Vinh Ha, Aarushi Rohaj, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 403-403
Open Access | Times Cited: 11
Targeting the peripheral neural-tumour microenvironment for cancer therapy
Dan Yaniv, Brandi J. Mattson, Sébastien Talbot, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 10, pp. 780-796
Closed Access | Times Cited: 9
Stress/cell death pathways, neuroinflammation, and neuropathic pain
Lu Li, Tian Li, Xinyu Qu, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 33-51
Closed Access | Times Cited: 16
Analgesic Mechanism of Emodin in Neuropathic Pain Through Inhibiting P2X4 Purinoceptor Signaling
Peng Chen, Qian Gong, Hao Wang, et al.
Molecular Neurobiology (2025)
Closed Access
Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain
Jurga Bernatonienė, Arūnas Ščiupokas, Dalia M. Kopustinskienė, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1799-1799
Open Access | Times Cited: 12
The Antinociceptive Role of Nrf2 in Neuropathic Pain: From Mechanisms to Clinical Perspectives
Kęstutis Petrikonis, Jurga Bernatonienė, Dalia M. Kopustinskienė, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1068-1068
Open Access | Times Cited: 3
Drug repurposing – A search for novel therapy for the treatment of diabetic neuropathy
Arpita Paul, Mohit Kumar, Parikshit Das, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113846-113846
Open Access | Times Cited: 13
In Silico Pharmacology and Drug Repurposing Approaches
Ghanshyam Parmar, Jay Mukesh Chudasama, Ashish Shah, et al.
(2023), pp. 253-281
Closed Access | Times Cited: 7
The Human SCN9AR185H Point Mutation Induces Pain Hypersensitivity and Spontaneous Pain in Mice
Yaping Xue, Mélanie Kremer, Maria del Mar Muñiz Moreno, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 9
SAFit2 ameliorates paclitaxel-induced neuropathic pain by reducing spinal gliosis and elevating pro-resolving lipid mediators
Saskia Wedel, Lisa Hahnefeld, Yannick Schreiber, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Semaglutide Ameliorates Diabetic Neuropathic Pain by Inhibiting Neuroinflammation in the Spinal Cord
Sing-Ong Lee, Yaswanth Kuthati, Wei-Hsiu Huang, et al.
Cells (2024) Vol. 13, Iss. 22, pp. 1857-1857
Open Access | Times Cited: 1
The FKBP51 Inhibitor SAFit2 Restores the Pain-Relieving C16 Dihydroceramide after Nerve Injury
Saskia Wedel, Lisa Hahnefeld, Mohamad Wessam Alnouri, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14274-14274
Open Access | Times Cited: 6
Recent advances to Neuroprotection: repurposing drugs against neuroinflammatory disorders
Wishah Bilal, Muhammad Babar Khawar, Ali Afzal, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 6241-6250
Closed Access | Times Cited: 2
The unpaved road of ayahuasca, a psychoactive brew, as a treatment for neuropathic pain: A review of mechanistic insights and clinical prospects
Bianca Castro dos Santos, Ana Kéren Gomes Reis, Ricardo Aparecido Baptista Nucci, et al.
Brain Behavior and Immunity Integrative (2024) Vol. 8, pp. 100087-100087
Open Access
Ist ein Muskarin-Antagonist bei diabetischer Polyneuropathie wirksam?
Claudia Sommer
InFo Neurologie + Psychiatrie (2024) Vol. 26, Iss. 10, pp. 22-23
Closed Access
Role of gut dysbiosis in drug-resistant epilepsy: Pathogenesis and available therapeutic strategies
Nidhi Khedpande, Kalyani Barve
Brain Research (2024) Vol. 1850, pp. 149385-149385
Closed Access
Roles of metformin and pioglitazone in regulating neurotoxic astrocyte activation in EAE mice
Suping Qin, B.D. Yuan, Jingjing Guo, et al.
Research Square (Research Square) (2024)
Open Access
Traditional Chinese medicine use in neuropathic pain: Targeting glial cell-mediated neuroinflammation
Wulin Liang, Mingqian Zhang, Xiyan Huang, et al.
Pharmacological Research - Modern Chinese Medicine (2023) Vol. 9, pp. 100322-100322
Open Access | Times Cited: 1
Page 1

Scroll to top